Dr. LI Rui is the deputy chief physician of pediatrics. She graduated from Soochow University School of Medicine with a master's degree, and has nearly 20 years of clinical experience. She serves on multiple professional committees including the Pediatric Group of the Integrated Chinese-Western Medicine Expert Working Committee at China Volunteers Association, the Allergy Specialty Committee of Jiangsu Maternal and Child Health Association, the Pediatric Genetic and Metabolic Disorders Group of the Rare Diseases Society at Suzhou Medical Association, and the School & Childhood Tuberculosis Prevention Branch of Suzhou Anti-Tuberculosis Association. Certified as a Higher Education Pediatrics Teacher, she lectures on pediatric theories and supervises clinical clerkships at Nanjing Medical University.

Dr. LI has extensive expertise in diagnosing and treating acute/chronic upper/lower respiratory tract infections, recurrent infant wheezing, childhood asthma, and chronic cough. Having completed advanced training in respiratory endoscopy at the Children's Hospital affiliated with Zhejiang University School of Medicine, she is highly proficient in performing pediatric bronchoscopy and bronchoalveolar lavage (BAL) procedures.

Dr. CHIOU serves as a dentist at Jiahui, Dr. CHIOU is a dedicated dentist with a multicultural background, having grown up in Canada , bilingual (English/Mandarin), had many years of studying aboard experience in North America, who earned his Bachelor of Dentistry from Shanghai Jiao Tong University School of Medicine, he brings years of clinical experience from French Dental Clinic, specializing in fixed（metal，ceramic brackets，functional orthopedic appliances）/invisible orthodontics (Invisalign, AngelAlign certified), comprehensive pediatric dentistry, prosthodontics of children, and malocclusion correction for teenager (LM, ETA certified). Dr. CHIOU works with a sense of responsibility, provide kind and professional services.

Dr. WANG Yu is currently a multi-point practitioner at Jiahui Health and serves as Director of the Head and Neck Surgery Department at Fudan University Shanghai Cancer Hospital. He holds the titles of Chief Physician, Clinical Professor, and Doctoral Supervisor. He earned his Master of Medicine (7-year program) from Shanghai Medical College, Fudan University (formerly Shanghai Medical University), and a Ph.D. in Oncology from the same institution. He later completed advanced training in the Department of Plastic Surgery at the University of Texas MD Anderson Cancer Center.

Dr. WANG has led or participated in over 30 municipal, provincial, national, and international multicenter basic and clinical research projects. He has initiated more than 10 investigator-initiated clinical trials on thyroid cancer and head and neck tumors, as well as projects promoting advanced medical technologies. As the first or corresponding author, he has published over 60 papers in core Chinese journals, including Chinese Journal of Surgery, Chinese Journal of Microsurgery, and Chinese Journal of Practical Surgery, as well as SCI-indexed journals such as Head & Neck, Thyroid, Clinical Cancer Research, Nature Communications, Cell Discovery, and Cancer Cell. He serves as an editorial board member and peer reviewer for multiple domestic and international journals and holds leadership roles in national and provincial academic societies. Dr. Wang has co-authored or contributed to several thyroid and head and neck oncology guidelines and consensus documents. His accolades include the China Anti-Cancer Association Science and Technology Award and other national honors.

Professional Affiliations
• Member, Thyroid Cancer Quality Control Expert Committee, National Cancer Center/National Cancer Quality Control Center
• Vice Chairman, Thyroid Cancer Professional Committee, China Anti-Cancer Association
• Vice Chairman, Head and Neck Tumor Committee, China Medicine Education Association
• Vice Chairman, General Surgery Branch, China International Exchange and Promotive Association for Medical and Health Care
• Vice Chairman, Thyroid Disease Branch, China International Exchange and Promotive Association for Medical and Health Care
• Vice Chairman, Laryngectomee Rehabilitation Committee, China Association of Rehabilitation of Disabled Persons
• Vice Chairman, Integrated Rehabilitation Committee for Thyroid Tumors, China Anti-Cancer Association
• Standing Committee Member, Head and Neck Tumor Committee, China Anti-Cancer Association
• Incoming Chairman, Head and Neck Tumor Committee, Shanghai Anti-Cancer Association

NI Zhao Hui, MD, PhD, Chief Physician, Professor, Doctoral Supervisor, and Postdoctoral Supervisor. Currently, she serves as the Director of the Department of General Internal Medicine, Director of Internal Medicine Residency Training, and Director of Internal Medicine Teaching and Research at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine. She is also the Chief Expert and the Chief Professor of Integrated Medicine for the Urinary System at the Shanghai Jiao Tong University School of Medicine. Dr. NI has been engaged in clinical and experimental research in the Department of Nephrology at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine since 1983, accumulating rich clinical experience in nephrology and internal medicine. She served as the Director of the Department of Nephrology at Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine from 2004 to 2020. In 2005 and 2006, she was a visiting scholar at the Yale University School of Medicine VA Medical Center and Brigham and Women’s Hospital and Harvard Medical School in the United States.

Dr. NI has been involved in clinical and basic research on the prevention and treatment of acute and chronic kidney diseases. She is skilled in diagnosing and treating various difficult and complicated kidney diseases, including IgA nephropathy, diabetic nephropathy, hypertensive nephrosclerosis, nephrotic syndrome, lupus nephritis, chronic renal insufficiency, hyperuricemia, gouty nephropathy, hematuria, and urinary tract infections. She is particularly adept at integrating traditional Chinese medicine with Western medicine in the treatment of these kidney diseases, including peritoneal dialysis and hemodialysis.

In recent years, Dr. NI has been responsible for and has obtained numerous national and provincial-level scientific research projects. As one of the 41 experts in the field of nephrology nationwide, she was selected for the 2024 list of the top 2% scientists in the fields of urology and nephrology (released jointly by Stanford University and the international authoritative publisher Elsevier) and was also included in the 2024 annual pre-release list of the top 1% highly cited scholars by China National Knowledge Infrastructure (CNKI). She has published over 300 academic papers, including more than 100 SCI papers, and has edited or co-edited 14 monographs. She served as the first deputy editor for the Standard Operating Procedures for Peritoneal Dialysis and as a core member of the editorial committee for the Chinese Expert Consensus on the Integrated Treatment of IgA Nephropathy, the Guidelines for the Integrated Prevention and Treatment of Chronic Renal Failure, and the Guidelines for the Integrated Diagnosis and Treatment of Diabetic Nephropathy.

Dr. NI holds various social positions, including Honorary Chairman of the Shanghai Medical Association Nephrology Branch, Chairman of the Shanghai Integrated Chinese and Western Medicine Association Metabolic and Immune Nephropathy Committee, Vice Chairman of the Shanghai Integrated Chinese and Western Medicine Association Expert Committee, Former Chairman of the Shanghai Integrated Chinese and Western Medicine Nephrology Branch, Vice Chairman of the Second Shanghai Hospital Management Association Blood Purification Branch, Standing Committee Member of the Ninth, Tenth, and Eleventh Sessions of the Chinese Medical Association Nephrology Branch, Standing Committee Member of the Third and Fourth Sessions of the Chinese Physician Association Nephrology Branch, Secretary-General of the Chinese Integrated Chinese and Western Medicine Association Nephrology Committee, Vice Chairman of the Chinese Hospital Management Association Blood Purification Branch, Vice Chairman of the Chinese Medical Promotion Association Blood Purification Branch, Vice President of the World Chinese Nephrologist Association, Member and East China Regional Leader of the Ministry of Health Nephrology Quality Control Center, and Vice President of the Chinese Female Physician Nephrology Association. She has been awarded numerous national awards, including the Fourth National Famous Doctor, the Fifth Chinese Female Physician Science and Technology Award, and the Baosteel Award.

Introduction
Dr. HAN Xiaodong is a multi-practice physician at Shanghai Jiahui Health and serves in the Department of Bariatric and Metabolic Surgery at Shanghai Sixth People’s Hospital. He holds a medical doctorate and is an associate chief physician. Dr. Han earned his Ph.D. in Surgery from Shanghai Jiao Tong University School of Medicine in 2009. Since 2011, he has focused on bariatric surgery, successfully performing over 2,000 procedures. He has contributed to 3 National Natural Science Foundation projects and 2 Shanghai Municipal Science and Technology Commission projects, and has co-authored 10 SCI papers in domestic and international journals, including 7 focused on bariatric and metabolic research. He is the sixth awardee of the Shanghai Medical Science and Technology Second Prize for "New Diagnostic and Therapeutic Technologies for Obesity and Diabetes, and Novel Mechanisms of Pathogenesis." In 2024, he was honored as one of the "Top Ten Public Welfare Figures" at the 10th Annual Medical Excellence Awards by Physician News, China Health Culture Association, and China Health Development Foundation.

Professional Affiliations
• Committee Member, Obesity and Metabolic Disease Surgery Working Group, Surgical Branch of the Chinese Medical Doctor Association
• Member, Bariatric and Metabolic Surgery Group, Surgical Branch of Shanghai Medical Association
• Committee Member, Popular Science Branch of Shanghai Medical Doctor Association
• Standing Committee Member, Endocrinology and Diabetes Branch of the Bethune Spirit Research Association
• Deputy Leader, Popular Science Working Group, Bariatric and Metabolic Rehabilitation Committee of the Chinese Rehabilitation Medical Association
• Co-Chair, Youth Alliance (CYFSO) of the Chinese Journal of Obesity and Metabolic Diseases (Electronic Edition)
• Editorial Board Member, Chinese Journal of Obesity and Metabolic Diseases (Electronic Edition)

ZHUANG Zhigang, MD, PhD., Chief Physician and Administrative Director of the Breast Surgery Department at the Obstetrics and Gynecology Hospital affiliated with Tongji University.

Professional Experience:
Since 2010, Dr. ZHUANG has visited UCLA in the United States, AKH in Austria, and the Mayo Clinic in the United States for academic exchanges and training. He serves as an editorial board member for the Journal of Tongji University. Dr. ZHUANG has led multiple scientific research projects, including the Shanghai Natural Science Foundation, Shanghai Municipal Commission of Health and Family Planning Medical Guidance Projects, and Shanghai Municipal Health Bureau projects. He has also participated in key medical field projects of the Shanghai Municipal Commission of Science and Technology. Dr. ZHUANG is the editor of Common Breast Diseases Consultation and Breast Cancer Consultation, and a contributing author to New Challenges in Communication with Cancer Patients. He has published over 60 papers, including more than 20 SCI-indexed articles, with more than 10 as the first or corresponding author.

Specialties:
• Diagnosis and treatment of benign tumors, breast lumps, nipple discharge, and related breast diseases；
• Diagnosis and treatment of breast cancer and soft tissue tumors；
• Oncoplastic surgery for malignant breast tumors.

Academic Appointments:
• Member of the American Society of Clinical Oncology (ASCO)
• Standing Committee Member of the Tumor Marker Professional Committee of the Chinese Anti-Cancer Association
• Standing Committee Member of the Breast Disease Professional Committee of the China Maternal and Child Health Association
• Member of the Oncoplastic Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care
• Chairman of the Breast Disease Prevention and Treatment Professional Committee of the Shanghai Maternal and Child Health Association
• Vice Chairman of the Thyroid and Breast Surgery Professional Committee of the Shanghai Association of Integrative Medicine
• Vice Chairman of the Breast Health and Popular Science Committee of the Health Science Branch of the Shanghai Association for Science and Technology
• Standing Committee Member of the Breast Cancer Professional Committee of the Shanghai Anti-Cancer Association
• Standing Committee Member of the Breast Disease Professional Committee of the Shanghai Association of Integrative Medicine

Dr. Xue Guanhua is currently a multi-site practicing physician at Jiahui Health, holds a Ph.D. in Surgery from the Vascular Surgery Department of Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine, and is a Chief Physician and Doctoral Supervisor. He has been awarded the "China University Students Jianhao Scholarship," "National Merit Student," and several awards in Shanghai. From June to September 2007, he was funded by the "Hundred Talents Program" of the School of Medicine at Shanghai Jiao Tong University to study at the Vascular Intervention Center of Leipzig University in Germany. In July 2015, he was invited to the University of Southern California and Stanford University Hospital for academic exchange. He has published 70 papers in core domestic and international journals, including 23 SCI papers (IF=141.90), with 7 papers scoring over 10. He has led two general projects of the National Natural Science Foundation of China, two projects of the Shanghai Municipal Science and Technology Commission (provincial and ministerial level), one "Industry-University-Research" special fund project of the Shanghai Pudong New Area Science and Technology Development Fund, and one Shanghai Medical-Engineering Cross-Innovation Project. He has participated in the compilation and translation of 5 monographs and is the chief editor of one, "Advances in the Diagnosis and Treatment of Aortoiliac Surgical Diseases." He has participated in the completion of three global multicenter clinical drug studies and holds 15 invention (utility) patents.

Social Appointments:
Chairman of the Aortoiliac Surgery Expert Committee of the Peripheral Vascular Diseases Committee of the Chinese Microcirculation Society
Vice Chairman of the Aortoiliac Surgery Group of the Vascular Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care
Vice Chairman of the Chinese Vascular Trauma Expert Committee of the International Union of Angiology (IUA)
Member of the International Society for Vascular Surgery (ISVS)
Vice President of the Translational Medicine Industry Branch of the National Health Industry Enterprise Management Association
Vice Chairman of the First Vascular Branch of the Overseas Returned Scholars Association of the Medical Doctor Association
Deputy Secretary-General of the Vascular Devices Branch of the China Medical Device Industry Association
Vice Chairman of the Vascular Surgery Committee of the Shanghai Medical Association
Honorary Chairman of the Vascular Surgery Committee of the Shanxi Health Management Association
Editorial Board Member of the "Chinese Journal of Vascular Surgery," "Chinese Journal of Vascular Surgery (Electronic Edition)," "Journal of Vascular and Endovascular Surgery," and "Journal of Vascular and Endovascular Surgery."

Dr. LYU Jingrong serves as the multi-site practice physician at Jiahui Health. He is titled as Chief Physician and Master’s Supervisor with a doctor degree in Medicine. He is currently the Teaching Director of the Otolaryngology Head and Neck Surgery Department at Shanghai Xinhua Hospital, a national key clinical specialty, and leads the pediatric laryngology and head and neck subspecialty. With extensive experience in clinical work and basic research in otolaryngology, he has published over twenty papers and reviews in authoritative international and domestic journals. He was a visiting scholar at the Massachusetts Eye and Ear Infirmary, Harvard University, USA. His current research focuses on congenital hearing disorders in children and vestibular medicine.

Dr.LYU holds several committee memberships, including:
• Youth Committee Member of the Head and Neck Group, Chinese Anti-Cancer Association Rehabilitation Society
• Youth Committee Member of the Pediatric Otolaryngology Group, Chinese Medical Doctor Association
• Youth Committee Member of the Head and Neck Tumor Expert Committee, Chinese Anti-Cancer Association
• Youth Committee Member of the Academic Guidance Committee, Head and Neck Group, Chinese Anti-Cancer Association Rehabilitation Society
• Youth Committee Member of the Pediatric Otolaryngology Youth Professional Committee, Chinese Medical Doctor Association
• Vice Chairman of the 19th Laryngology Group, 18th Shanghai Medical Association Otolaryngology Head and Neck Surgery Branch
• Member of the 18th Shanghai Otolaryngology Head and Neck Surgery Laryngology Group
• Member of the Head and Neck Surgery Group, 6th Otolaryngology Professional Committee, Shanghai Association of Integrative Medicine

Dr. LYU is proficient in diagnosing and treating various otolaryngological diseases. His main research and clinical focuses include:
1. Minimally invasive surgical treatment for pediatric adenoid hypertrophy, tonsillar hypertrophy, and secretory otitis media.
2. Surgical treatment of congenital neck masses in children, such as thyroglossal duct cysts, branchial cleft cysts, and fistulas.
3. Surgical treatment of neck masses, submandibular gland, and parotid gland tumors in both children and adults, as well as various benign and malignant laryngeal tumors.
4. Minimally invasive surgeries for sinusitis, nasal polyps, and nasal tumors.

His primary scientific research areas include the pathogenesis of pediatric adenoid hypertrophy and its developmental impacts, the pathogenesis of pediatric neck tumors, screening for congenital hearing disorders in children, and medical research related to vestibular development. 

Dr. GE Di, Deputy Director of the Thoracic Surgery Department and Director of the Lung Cancer Center at Zhongshan Hospital, affiliated with Fudan University, doctoral supervisor.

Specialties:
• Differential diagnosis of small pulmonary nodules and management of locally advanced lung cancer;
• Minimally invasive surgery and conventional thoracotomy for lung, esophageal, and mediastinal tumors;
• Carinal surgery, sleeve lobectomy, esophageal resection with colonic interposition, completion pneumonectomy, and radical esophagostomy after partial gastrectomy;

Academic appointment
• Vice Chairman of the Thoracic Surgery Branch of the Shanghai Medical Association;
• Member of the Society of Thoracic Surgeons (STS), USA;
• Fellow of the American College of Chest Physicians (FCCP);
• Vice Chairman of the Thoracic Surgery Branch of the Shanghai Association of Integrative Medicine;
• Member of the Lung Cancer Study Group of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association;
• Vice Chairman of the Lung Cancer Study Group of the Shanghai Anti-Cancer Association;
• Vice Chairman of the Thoracic Surgery Committee of the Chinese Medical Education Association;
• Standing Committee Member of the Thoracic Surgery Professional Committee of the China Medical Foundation;